Climb Bio, Inc.

Ownership Transactions Reported by 17 Insiders

Symbol
CLYM on Nasdaq
Location
20 William Street, Suite 145, Wellesley Hills, MA

Insiders trading volume in the past year

Climb Bio, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Ai Eti Llc 10%+ Owner $62.6M Aug 12, 2021
Ra Capital Management, L.P. Director, 10%+ Owner $11M +$50M Jun 27, 2024
Aoife Brennan President and CEO, Director $1.98M Jun 27, 2024
Stephen Basil Thomas Director $1.47M Jun 27, 2024
Brett Kaplan Chief Operating Officer $618K Aug 26, 2024
Emily Pimblett Chief Accounting Officer $300K -$18.7K -5.87% Sep 18, 2024
Valerie Morisset Evp, R&D And Cso $250K -$3.45M -93.2% Jul 19, 2024
Douglas E. Williams Director Nov 11, 2024
Liam Ratcliffe Director Jun 26, 2024
Judith Dunn Director Jun 26, 2024
Andrew David Levin Executive Chairman, Director Jun 26, 2024
Simon Tate Director Jun 26, 2024
Robert Azelby President & CEO, Director Oct 31, 2022
Adam Joseph Rosenberg Director Jun 26, 2024
Erin Lavelle Coo & Cfo Oct 31, 2022
James B. Bucher EVP and General Counsel Oct 31, 2022
Leone D. Patterson Director May 19, 2022

Recent Insider Transactions by Companies or Individuals for Climb Bio, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.